Christine Bestvina to Immunotherapy
This is a "connection" page, showing publications Christine Bestvina has written about Immunotherapy.
Connection Strength
0.751
-
Immunotherapy partners after progression: Right place, right time? Cancer. 2023 01 15; 129(2):181-183.
Score: 0.555
-
CDKN2A loss-of-function predicts immunotherapy resistance in non-small cell lung cancer. Sci Rep. 2021 10 08; 11(1):20059.
Score: 0.128
-
Predictors of Pneumonitis in Combined Thoracic Stereotactic Body Radiation Therapy and Immunotherapy. Int J Radiat Oncol Biol Phys. 2022 11 15; 114(4):645-654.
Score: 0.034
-
Alliance A082002 -a randomized phase II/III trial of modern immunotherapy-based systemic therapy with or without SBRT for PD-L1-negative, advanced non-small cell lung cancer. Clin Lung Cancer. 2022 07; 23(5):e317-e320.
Score: 0.033